Actively Recruiting
Validation of Hematological Indices
Led by Petrovsky National Research Centre of Surgery · Updated on 2024-11-25
200
Participants Needed
1
Research Sites
132 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The hypothesis of the study is that hematological indices (neutrophil to lymphocyte ratio, platelet to lymphocyte ratio and systemic index of inflammation) may be predictors of infectious complications and multiple organ dysfunction in patients after cardiac surgery.
CONDITIONS
Official Title
Validation of Hematological Indices
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age from 18 to 80 years
- Scheduled for cardiac surgery
- Surgery performed with cardiopulmonary bypass
- Voluntary informed consent to participate in the study
You will not qualify if you...
- Patient refusal to participate in the study
- Transfer to another medical institution
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Petrovsky National Reasearch Centre of Surgery
Moscow, Russia, 119991
Actively Recruiting
Research Team
M
Maxim A. Babaev, D.M.
CONTACT
O
Oxana O. Grin
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here